Latest News

National Geographic interviewed Eva Feldman, M.D., Ph.D., for a story about a new mouse study that shows popular weight loss drugs could lower inflammation and what this means for the treatment of neurodegenerative diseases.

In the area of autoimmune and nerve disorders, people usually think of CIDP (chronic inflammatory demyelinating polyradiculoneuropathy) or Guillain-Barre syndrome. However, there is another autoimmune neuropathy that often goes undiagnosed or mischaracterized as CIDP, called Anti-MAG (myelin-associated-glycoprotein) neuropathy.

U.S. News & World Report featured Drs. Evan Reynolds and Brian Callaghan, whose recent study found that total and out-of-pocket costs for diabetics run hundreds to thousands of dollars more than regular medical expenses for people without diabetes.

Michigan Medicine's Health Lab covered reaseach by a team lead by Drs. Evan Reynolds and Brian Callaghan that found that diabetes care providers should account for impacts caused by financial insecurity.

The American Academy of Neurology's "official news source" interviewed Brian Callaghan, M.D., on a story that looked at the effects of popular weight loss drugs on neurologic disorders.

A team led by Dr. Stephen Goutman investigated if particular hobbies and exercise affect ALS risk, survival, location of initial ALS symptoms and onset age. Their findings were published in the Journal of Neurological Sciences .

Nutritional Insight interviewed Brian Callaghan, M.D., on new research published in the Journal of Nutrition, Health & Aging .

Research led by Dr. Bhumsoo Kim offers a new theory on what drives Alzheimer’s disease progression in metabolic syndrome.

In "A Role for Neurologists in Diabetic Peripheral Neuropathy," Medscape Medical News interviewed Eva Feldman, MD, PhD, following her plenary talk at the World Congress of Neurology 2023.